Logo image of LLY.DE

ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis

Europe - FRA:LLY - US5324571083 - Common Stock

884.6 EUR
+2.4 (+0.27%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

6

Overall LLY gets a fundamental rating of 6 out of 10. We evaluated LLY against 54 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY shows excellent growth, but is valued quite expensive already. With these ratings, LLY could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

LLY had positive earnings in the past year.
In the past year LLY had a positive cash flow from operations.
LLY had positive earnings in each of the past 5 years.
LLY had a positive operating cash flow in each of the past 5 years.
LLY.DE Yearly Net Income VS EBIT VS OCF VS FCFLLY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

LLY's Return On Assets of 16.02% is amongst the best of the industry. LLY outperforms 90.74% of its industry peers.
LLY's Return On Equity of 77.38% is amongst the best of the industry. LLY outperforms 98.15% of its industry peers.
The Return On Invested Capital of LLY (28.84%) is better than 96.30% of its industry peers.
LLY had an Average Return On Invested Capital over the past 3 years of 21.71%. This is significantly above the industry average of 14.51%.
The last Return On Invested Capital (28.84%) for LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.84%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
LLY.DE Yearly ROA, ROE, ROICLLY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

The Profit Margin of LLY (30.99%) is better than 98.15% of its industry peers.
In the last couple of years the Profit Margin of LLY has declined.
Looking at the Operating Margin, with a value of 44.41%, LLY belongs to the top of the industry, outperforming 98.15% of the companies in the same industry.
LLY's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 83.03%, LLY belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
LLY.DE Yearly Profit, Operating, Gross MarginsLLY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LLY is creating value.
LLY has about the same amout of shares outstanding than it did 1 year ago.
LLY has less shares outstanding than it did 5 years ago.
LLY has a worse debt/assets ratio than last year.
LLY.DE Yearly Shares OutstandingLLY.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY.DE Yearly Total Debt VS Total AssetsLLY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 8.19 indicates that LLY is not in any danger for bankruptcy at the moment.
LLY has a Altman-Z score of 8.19. This is amongst the best in the industry. LLY outperforms 94.44% of its industry peers.
LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
LLY has a Debt to FCF ratio of 6.60. This is comparable to the rest of the industry: LLY outperforms 40.74% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that LLY has dependencies on debt financing.
LLY's Debt to Equity ratio of 1.72 is on the low side compared to the rest of the industry. LLY is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.19
ROIC/WACC3.29
WACC8.77%
LLY.DE Yearly LT Debt VS Equity VS FCFLLY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

A Current Ratio of 1.55 indicates that LLY should not have too much problems paying its short term obligations.
LLY has a better Current ratio (1.55) than 61.11% of its industry peers.
A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.24, LLY is in the better half of the industry, outperforming 68.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY.DE Yearly Current Assets VS Current LiabilitesLLY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.22% over the past year.
Measured over the past years, LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
Looking at the last year, LLY shows a very strong growth in Revenue. The Revenue has grown by 45.41%.
LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%

3.2 Future

The Earnings Per Share is expected to grow by 30.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.43% on average over the next years. This is quite good.
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LLY.DE Yearly Revenue VS EstimatesLLY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
LLY.DE Yearly EPS VS EstimatesLLY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.85, the valuation of LLY can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as LLY.
Compared to an average S&P500 Price/Earnings ratio of 25.89, LLY is valued quite expensively.
Based on the Price/Forward Earnings ratio of 33.14, the valuation of LLY can be described as expensive.
62.96% of the companies in the same industry are cheaper than LLY, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, LLY is valued at the same level.
Industry RankSector Rank
PE 46.85
Fwd PE 33.14
LLY.DE Price Earnings VS Forward Price EarningsLLY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LLY is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, LLY is valued a bit more expensive than the industry average as 64.81% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 151.52
EV/EBITDA 35.62
LLY.DE Per share dataLLY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of LLY may justify a higher PE ratio.
LLY's earnings are expected to grow with 42.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)2.83
EPS Next 2Y54.64%
EPS Next 3Y42.29%

4

5. Dividend

5.1 Amount

LLY has a yearly dividend return of 0.59%, which is pretty low.
LLY's Dividend Yield is comparable with the industry average which is at 3.01.
Compared to an average S&P500 Dividend Yield of 2.44, LLY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
LLY.DE Yearly Dividends per shareLLY.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
LLY.DE Yearly Income VS Free CF VS DividendLLY.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B
LLY.DE Dividend Payout.LLY.DE Dividend Payout, showing the Payout Ratio.LLY.DE Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

FRA:LLY (11/14/2025, 7:00:00 PM)

884.6

+2.4 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-04 2026-02-04/bmo
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap837.24B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80
Price Target788.08 (-10.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend4.24
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)2.59%
PT rev (3m)-6.79%
EPS NQ rev (1m)2.11%
EPS NQ rev (3m)2.55%
EPS NY rev (1m)2.48%
EPS NY rev (3m)7.64%
Revenue NQ rev (1m)1.94%
Revenue NQ rev (3m)2.48%
Revenue NY rev (1m)1.37%
Revenue NY rev (3m)4.24%
Valuation
Industry RankSector Rank
PE 46.85
Fwd PE 33.14
P/S 16.41
P/FCF 151.52
P/OCF 60.72
P/B 40.99
P/tB 85.18
EV/EBITDA 35.62
EPS(TTM)18.88
EY2.13%
EPS(NY)26.69
Fwd EY3.02%
FCF(TTM)5.84
FCFY0.66%
OCF(TTM)14.57
OCFY1.65%
SpS53.9
BVpS21.58
TBVpS10.38
PEG (NY)0.58
PEG (5Y)2.83
Graham Number95.75
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.84%
ROICexc 33.25%
ROICexgc 41.06%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.19
F-Score7
WACC8.77%
ROIC/WACC3.29
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y30.03%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%

ELI LILLY & CO / LLY.DE FAQ

What is the fundamental rating for LLY stock?

ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.


What is the valuation status for LLY stock?

ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.


What is the financial health of ELI LILLY & CO (LLY.DE) stock?

The financial health rating of ELI LILLY & CO (LLY.DE) is 5 / 10.


What is the expected EPS growth for ELI LILLY & CO (LLY.DE) stock?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 80.9% in the next year.